Clinical Report: Integrating Biofeedback with Vestibular Rehabilitation for Managing Vestibular Migraine
Overview
This study evaluates the efficacy of combined biofeedback and vestibular rehabilitation therapy in patients with vestibular migraine (VM). Results indicate that this integrated approach improves clinical outcomes compared to individual therapies.
Background
Vestibular migraine is a common cause of recurrent vertigo, yet treatment options remain limited. The integration of biofeedback with vestibular rehabilitation may offer a non-pharmacological approach to managing this condition.
Data Highlights
Group
Total Effective Rate
p-value
Routine Intervention (A)
67.57%
-
Vestibular Rehabilitation (B)
75.68%
-
Biofeedback Therapy (C)
78.38%
-
Combined Therapy (D)
94.59%
0.035
Key Findings
Combined therapy achieved a total effective rate of 94.59%, higher than other groups.
Group D showed improvements in anxiety and depression scores.
Vertigo disability and balance function improved in the combined therapy group.
Serum levels of 5-hydroxytryptamine and γ-aminobutyric acid increased, while calcitonin gene-related peptide and acetylcholine levels decreased in Group D.
Vestibular function parameters improved with combined therapy.
Clinical Implications
The findings indicate that integrating biofeedback with vestibular rehabilitation may improve treatment outcomes for patients with vestibular migraine.
Conclusion
The study supports the use of combined biofeedback and vestibular rehabilitation as a treatment strategy for vestibular migraine.
